The virology market in APAC is expected to grow from US$ 931.92 million in 2021 to US$ 1,234.44 million by 2028; it is estimated to grow at a CAGR of 4.1% from 2021 to 2028.
China, Japan, India, South Korea, and Australia are major economies in APAC. Countries in Asia Pacific is attractive outsourcing locations for the pharmaceutical and biopharmaceutical industries across the world. Low manufacturing and operating costs and recent growth in the pharmaceutical industry in China and India are key factors driving the growth of the virology-related markets in these countries. Moreover, the growing domestic market and its pipelines are opening new access for the manufacturing of generic drugs in Asia Pacific. In addition, several contract-based organizations are expanding their manufacturing capacities in developing nations to meet the rising demand for products, such as vaccines. Thus, the emerging markets are likely to create lucrative opportunities for the growth of the APAC virology market in the coming years.COVID-19 has created an unprecedented public health emergency globally. It has demonstrated, emerging infectious diseases represent an existential threat worldwide. Rapid urbanization, deforestation, intensive agriculture, livestock rearing practices, and globalization are increasing opportunities for animal-to-human contacts and epidemics in the region. Urbanization is creating greater potential for epidemics and pandemics, as a large population now lives in cities. In addition, many countries were able to contain the COVID-19 based on previous epidemics. For instance, the South Korean central government began investing in domestic R&D of diagnostic reagents necessary for infectious disease testing. From 2017, it has invested approximately US$ 25 million in infectious disease diagnosis technology. The testing technologies developed by commercial manufacturers through government investments in R&D, including artificial intelligence (AI), proved critical for the government’s rapid launch of an effective COVID-19 response strategy. However, The COVID-19 pandemic has had a major impact on the essential HIV health services in the South East Asia Region, putting the growth at risk over the last two decades. COVID-19 has disrupted essential services causing considerable delays in the delivery of medicines and other health commodities. Changing priorities for HIV clinics and healthcare workers, travel restrictions, non-availability of public and limited private transportation, and worsening socio-economic contexts affected the continuity of essential HIV services. In the Philippines, more than 70% of delays or reductions in the number of visits to HIV clinics have been recorded since the pandemic, according to a survey conducted by Gilead Sciences. HIV and AIDS represented the most recent global pandemic, and the Global Fund has made enormous progress over the past 20 years. According to the study, over 82% of prescribers in India reported a decrease or delay of visits of people living with HIV. COVID-19 has also negatively impacted the uptake of HIV tests, and around 46% of the at-risk population reported a decrease in taking HIV tests during COVID-19. The main reasons for reduced testing were exposure to COVID-19 (62%) and travel restrictions (46%), as HIV tests were mostly only accessible at point-of-care. Therefore, it has negatively affected HIV care and other virus infections.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive virology market. The APAC virology market is expected to grow at a good CAGR during the forecast period.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
APAC Virology Market Segmentation
APAC Virology Market – By Type
- Diagnostic Test
- DNA Virus Testing
- RNA Virus Testing
- Others
- Viral Infection Controlling Techniques
- Active Prophylaxis
- Passive Prophylaxis
- Antiviral Therapeutics
- Virucidal Agents
- Antiviral Agents
- Immunomodulators
- Interferons
APAC Virology Market – By Application
- Skin and Soft Tissue Infections
- Respiratory Tract Infections
- GI Tract Infections
- Sexually Transmitted Diseases
- Urinary Tract Infections
- Others
APAC Virology Market – By End User
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical and Biotechnological Companies
- Research and Academic Institutes
APAC Virology Market- By Country
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
APAC Virology Market-Companies Mentioned
- Abbott
- AbbVie Inc.
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- GlaxoSmithKline Plc
- Illumina, Inc.
- Johnson and Johnson Services, Inc.
- QIAGEN
- Siemens AG
- Thermo Fisher Scientific Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Virology Market – By Type
1.3.2 APAC Virology Market – By Application
1.3.3 APAC Virology Market – By End User
1.3.4 APAC Virology Market– By Country
2. APAC Virology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Virology Market– Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Virology Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Viral Infectious Diseases
5.1.2 Increasing Product Launches
5.2 Market Restraints
5.2.1 Availability of Alternative Products and High Cost of Production of Products
5.3 Market Opportunities
5.3.1 Surging Growth in Several Economies
5.4 Future Trends
5.4.1 Continuous Demand for Cost-Effective Products
5.5 Impact Analysis
6. Virology Market– APAC Analysis
6.1 APAC Virology Market Revenue Forecast and Analysis
7. APAC Virology Market Analysis – By Type
7.1 Overview
7.2 APAC Virology Market Revenue Share, by Type (2021 and 2028)
7.3 Diagnostic Test
7.3.1 Overview
7.3.2 Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Deoxyribonucleic Acid (DNA) Virus Testing
7.3.2.1.1 Overview
7.3.2.1.2 DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Ribonucleic Acid (RNA) Virus Testing
7.3.2.2.1 Overview
7.3.2.2.2 RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Others
7.3.2.3.1 Overview
7.3.2.3.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Viral Infection Controlling Techniques
7.4.1 Overview
7.4.2 Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Active Prophylaxis
7.4.2.1.1 Overview
7.4.2.1.2 Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.2 Passive Prophylaxis
7.4.2.2.1 Overview
7.4.2.2.2 Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Antiviral Therapeutics
7.5.1 Overview
7.5.2 Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.1 Virucidal Agents
7.5.2.1.1 Overview
7.5.2.1.2 Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.2 Antiviral Agents
7.5.2.2.1 Overview
7.5.2.2.2 Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.3 Immunomodulators
7.5.2.3.1 Overview
7.5.2.3.2 Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Interferons
7.6.1 Overview
7.6.2 Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8. APAC Virology Market Analysis – By Application
8.1 Overview
8.2 APAC Virology Market, by Application 2021 & 2028 (%)
8.3 Skin and Soft Tissue Infections
8.3.1 Overview
8.3.2 Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Respiratory Tract Infections
8.4.1 Overview
8.4.2 Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.5 GI Tract Infections
8.5.1 Overview
8.5.2 GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Sexually Transmitted Diseases
8.6.1 Overview
8.6.2 Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Urinary Tract Infections
8.7.1 Overview
8.7.2 Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9. APAC Virology Market Analysis – By End User
9.1 Overview
9.2 APAC Virology Market Revenue Share, by End User (2021 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pharmaceutical and Biotechnological Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Research and Academic Institutes
9.6.1 Overview
9.6.2 Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)
10. APAC Virology Market – Country Analysis
10.1.1 Overview
10.1.2 Asia Pacific: Virology Market, by Country, 2021 & 2028 (%)
10.1.2.1 China: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 China: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 China: Virology Market, By Type, 2019–2028 (USD Million)
10.1.2.1.2.1 China: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.1.2.2 China: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.1.2.3 China: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.1.3 China: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.1.4 China: Virology Market, by End User, 2019–2028 (USD Million)
10.1.2.2 Japan: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Japan: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Japan: Virology Market, By Type, 2019–2028 (USD Million)
10.1.2.2.2.1 Japan: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.2.2.2 Japan: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.2.2.3 Japan: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.2.3 Japan: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.2.4 Japan: Virology Market, by End User, 2019–2028 (USD Million)
10.1.2.3 India: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 India: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 India: Virology Market, By Type, 2019–2028 (USD Million)
10.1.2.3.2.1 India: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.3.2.2 India: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.3.2.3 India: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.3.3 India: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.3.4 India: Virology Market, by End User, 2019–2028 (USD Million)
10.1.2.4 South Korea: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.1 South Korea: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2 South Korea: Virology Market, By Type, 2019–2028 (USD Million)
10.1.2.4.2.1 South Korea: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.4.2.2 South Korea: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.4.2.3 South Korea: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.4.3 South Korea: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.4.4 South Korea: Virology Market, by End User, 2019–2028 (USD Million)
10.1.2.5 Australia: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.1 Australia: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.2 Australia: Virology Market, By Type, 2019–2028 (USD Million)
10.1.2.5.2.1 Australia: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.5.2.2 Australia: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.5.2.3 Australia: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.5.3 Australia: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.5.4 Australia: Virology Market, by End User, 2019–2028 (USD Million)
10.1.2.6 Rest of Asia Pacific: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.1 Rest of Asia Pacific: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.2 Rest of Asia Pacific: Virology Market, By Type, 2019–2028 (USD Million)
10.1.2.6.2.1 Rest of Asia Pacific: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.6.2.2 Rest of Asia Pacific: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.6.2.3 Rest of Asia Pacific: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.6.3 Rest of Asia Pacific: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.6.4 Rest of Asia Pacific: Virology Market, by End User, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on APAC Virology Market
11.1 Overview
12. APAC Virology Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Abbott
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Johnson and Johnson Services, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. HOFFMANN-LA ROCHE LTD.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 THERMO FISHER SCIENTIFIC INC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 QIAGEN
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Illumina, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Siemens AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 GlaxoSmithKline Plc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 AbbVie Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Gilead Sciences, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC Virology Market Revenue and Forecast to 2028 (US$ Million)
Table 2. China: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 3. China Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 4. China Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 5. China Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 6. China: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. China: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 8. Japan: Virology Market, By Type– Revenue and Forecast to 2028 (USD Million)
Table 9. Japan Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 10. Japan Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 11. Japan Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 12. Japan: Virology Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 13. Japan: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 14. India: Virology Market, By Type– Revenue and Forecast to 2028 (USD Million)
Table 15. India Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 16. India Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 17. India Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 18. India: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. India: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 21. South Korea Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 22. South Korea Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 23. South Korea Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 24. South Korea: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 25. South Korea: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 26. Australia: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 27. Australia Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 28. Australia Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 29. Australia Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 30. Australia: Virology Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 31. Australia: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Asia Pacific: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Asia Pacific Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of Asia Pacific Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of Asia Pacific Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Asia Pacific: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 37. Rest of Asia Pacific: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 38. Organic Developments Done by Companies
Table 39. Inorganic Developments Done by Companies
Table 40. Glossary of Terms, APAC Virology Market
LIST OF FIGURES
Figure 1. APAC Virology Market Segmentation
Figure 2. APAC Virology Segmentation, By Country
Figure 3. APAC Virology Market Overview
Figure 4. Antiviral Therapeutics Held the Largest Share of the Type Segment in APAC Virology Market
Figure 5. Respiratory Tract Infections Held the Largest Share of the Application Segment in APAC Virology Market
Figure 6. India to Show Significant Growth During Forecast Period
Figure 7. APAC PEST Analysis
Figure 8. APAC Virology Market: Impact Analysis of Drivers and Restraints
Figure 9. APAC Virology Market– Revenue Forecast and Analysis – 2019- 2028
Figure 10. APAC Virology Market Revenue Share, by Type (2021 and 2028)
Figure 11. APAC Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. APAC DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. APAC RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. APAC Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. APAC Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. APAC Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. APAC Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. APAC Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. APAC Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. APAC Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. APAC Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. APAC Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. APAC Virology Market, by Application 2021 & 2028 (%)
Figure 24. APAC Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. APAC Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. APAC GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. APAC Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. APAC Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. APAC Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. APAC Virology Market Revenue Share, by End User (2021 and 2028)
Figure 31. APAC Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. APAC Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. APAC Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. APAC Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Asia Pacific: Virology Market, by Key Country – Revenue (2021) (USD Million)
Figure 36. Asia Pacific: Virology Market, by Country, 2021 & 2028 (%)
Figure 37. China: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Japan: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. India: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. South Korea: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Australia: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Rest of Asia Pacific: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. Impact of COVID-19 Pandemic on Virology Market in APAC Countries
- Abbott
- AbbVie Inc.
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- GlaxoSmithKline Plc
- Illumina, Inc.
- Johnson and Johnson Services, Inc.
- QIAGEN
- Siemens AG
- Thermo Fisher Scientific Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Virology Market
Nov 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Nov 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Nov 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Nov 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Nov 2021